Immatics (IMTX) had the highest return between 2014 and 2019 by a US stock in the Biotechnology Industry, returning 207,900%.

ASSET	YEARS	% RETURN
Immatics (IMTX)	2014-2019	207,900%
GeoVax Labs (GOVX)	2014-2019	32,627.27%
AquaBounty Technologies (AQB)	2014-2019	30,038.89%
Neurocrine Biosciences (NBIX)	2014-2019	1,059.55%
Amarin (AMRN)	2014-2019	982.83%
Galapagos NV ADR (GLPG)	2014-2019	878.2%
Evotec SE ADR (EVO)	2014-2019	856.39%
argenx NV ADR (ARGX)	2014-2019	796.76%
Lexaria Bioscience (LEXX)	2014-2019	701.44%
EXACT Sciences (EXAS)	2014-2019	695.18%
Theratechnologies (THTX)	2014-2019	633.33%
Kodiak Sciences (KOD)	2014-2019	619.5%
Ascendis Pharma A-S (ASND)	2014-2019	547.07%
Sarepta Therapeutics (SRPT)	2014-2019	536.92%
Fennec Pharmaceuticals (FENC)	2014-2019	500.93%
Arrowhead Pharmaceuticals (ARWR)	2014-2019	490.05%
BeiGene (ONC)	2014-2019	472.18%
Genmab A-S (GMAB)	2014-2019	456.58%
Vericel Corp Ord (VCEL)	2014-2019	438.7%
Krystal Biotech (KRYS)	2014-2019	427.43%
Aurinia Pharmaceuticals (AUPH)	2014-2019	414.51%
Cidara Therapeutics (CDTX)	2014-2019	380%
Esperion Therapeutics (ESPR)	2014-2019	331.79%
Uniqure (QURE)	2014-2019	321.53%
Amicus Therapeutics (FOLD)	2014-2019	314.47%